Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
243 hedge funds and large institutions have $2.58B invested in Inari Medical, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 88 increasing their positions, 75 reducing their positions, and 36 closing their positions.
391% more call options, than puts
Call options by funds: $7.61M | Put options by funds: $1.55M
39% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 36
17% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 75
5% more funds holding
Funds holding: 231 → 243 (+12)
3% less capital invested
Capital invested by funds: $2.65B → $2.58B (-$76.1M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$55.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$34.9M |
| 3 |
AC
Armistice Capital
New York
|
+$34.9M |
| 4 |
Jennison Associates
New York
|
+$27.6M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$16.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$104M |
| 2 |
Millennium Management
New York
|
-$39.1M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$37.1M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$22.4M |
| 5 |
Morgan Stanley
New York
|
-$20.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
276
Fuller & Thaler Asset Management
San Mateo,
California
| – | -$1.28K | -27 | Closed |
|
277
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$912 | -19 | Closed |
|
|
S
278
Sachetta
Lynnfield,
Massachusetts
| – | -$844 | -13 | Closed |
|
279
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$48 | -1 | Closed |
|
NARI Hedge Fund Activity: Q2 2024 in Review
243 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q2 2024, worth a combined $2.58B — down 2.9% from $2.65B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new NARI positions and 36 closed out — a net gain of 14 holders — while 88 added to existing stakes and 75 trimmed.
The largest buyer was UBS AM, adding an estimated $55.3M. The largest seller was Franklin Resources, cutting an estimated $104M.
- 243 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q2 2024, up from 231 in Q1 2024.
- Funds reported $2.58B of Inari Medical, Inc. Common Stock stock for Q2 2024, down 2.9% quarter-over-quarter.
- 50 funds opened new Inari Medical, Inc. Common Stock positions in Q2 2024 and 36 closed out, a net change of +14 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q2 2024 was UBS AM, an estimated $55.3M added.
- The largest Inari Medical, Inc. Common Stock seller in Q2 2024 was Franklin Resources, an estimated $104M sold.
Based on aggregated 13F filings for Q2 2024.